Gene expression signatures as candidate biomarkers of response to PD-1 blockade in non-small cell lung cancers
Aiba, Tomoiki, Hattori, Chieko, Sugisaka, Jun, Shimizu, Hisashi, Ono, Hirotaka, Domeki, Yutaka, Saito, Ryohei, Kawana, Sachiko, Kawashima, Yosuke, Terayama, Keisuke, Toi, Yukihiro, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Suzuki, Yutaka, Niida, Atsushi, Sugawara, Shunichi
Published in PloS one (29.11.2021)
Published in PloS one (29.11.2021)
Get full text
Journal Article
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge
Sugisaka, Jun, Toi, Yukihiro, Kawashima, Yosuke, Domeki, Yutaka, Aiba, Tomoiki, Kawana, Sachiko, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Sugawara, Shunichi
Published in Thoracic cancer (01.11.2023)
Published in Thoracic cancer (01.11.2023)
Get full text
Journal Article
Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer
Ono, Kana, Ono, Hirotaka, Toi, Yukihiro, Sugisaka, Jun, Aso, Mari, Saito, Ryohei, Kawana, Sachiko, Aiba, Tomoiki, Odaka, Tetsuo, Matsuda, Suguru, Saito, Shin, Narumi, Akane, Ogasawara, Takahiro, Shimizu, Hisashi, Domeki, Yutaka, Terayama, Keisuke, Kawashima, Yosuke, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro, Sugawara, Shunichi
Published in Cancer medicine (Malden, MA) (01.07.2021)
Published in Cancer medicine (Malden, MA) (01.07.2021)
Get full text
Journal Article
Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab
Toi, Yukihiro, Sugawara, Shunichi, Kawashima, Yosuke, Aiba, Tomoiki, Kawana, Sachiko, Saito, Ryohei, Tsurumi, Kyoji, Suzuki, Kana, Shimizu, Hisashi, Sugisaka, Jun, Ono, Hirotaka, Domeki, Yutaka, Terayama, Keisuke, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro
Published in The oncologist (Dayton, Ohio) (01.11.2018)
Published in The oncologist (Dayton, Ohio) (01.11.2018)
Get full text
Journal Article
Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer
Toi, Yukihiro, Sugawara, Shunichi, Sugisaka, Jun, Ono, Hirotaka, Kawashima, Yosuke, Aiba, Tomoiki, Kawana, Sachiko, Saito, Ryohei, Aso, Mari, Tsurumi, Kyoji, Suzuki, Kana, Shimizu, Hisashi, Domeki, Yutaka, Terayama, Keisuke, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro
Published in JAMA oncology (01.03.2019)
Published in JAMA oncology (01.03.2019)
Get more information
Journal Article
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer
Aso, Mari, Toi, Yukihiro, Sugisaka, Jun, Aiba, Tomoiki, Kawana, Sachiko, Saito, Ryohei, Ogasawara, Takahiro, Tsurumi, Kyoji, Ono, Kana, Shimizu, Hisashi, Domeki, Yutaka, Terayama, Keisuke, Kawashima, Yosuke, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro, Sugawara, Shunichi
Published in The oncologist (Dayton, Ohio) (01.03.2020)
Published in The oncologist (Dayton, Ohio) (01.03.2020)
Get full text
Journal Article
Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
Sugisaka, Jun, Toi, Yukihiro, Taguri, Masataka, Kawashima, Yosuke, Aiba, Tomoiki, Kawana, Sachiko, Saito, Ryohei, Aso, Mari, Tsurumi, Kyoji, Suzuki, Kana, Shimizu, Hisashi, Ono, Hirotaka, Domeki, Yutaka, Terayama, Keisuke, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro, Sugawara, Shunichi
Published in JMA journal (15.01.2020)
Published in JMA journal (15.01.2020)
Get full text
Journal Article
Single-sample enrichment analysis identified predictive biomarker candidates for nivolumab in patients with non-small cell lung cancer
Aiba, Tomoiki, Hattori, Chieko, Sugisaka, Jun, Shimizu, Hisashi, Ono, Hirotaka, Domeki, Yutaka, Saito, Ryohei, Kawana, Sachiko, Kawashima, Yousuke, Terayama, Keisuke, Toi, Yukihiro, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Suzuki, Yutaka, Niida, Atsushi, Sugawara, Shunichi
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study
Toi, Yukihiro, Kimura, Yuichiro, Domeki, Yutaka, Kawana, Sachiko, Aiba, Tomoiki, Ono, Hirotaka, Aso, Mari, Tsurumi, Kyoji, Suzuki, Kana, Shimizu, Hisashi, Sugisaka, Jun, Saito, Ryohei, Terayama, Keisuke, Kawashima, Yosuke, Nakamura, Atsushi, Yamanda, Shinsuke, Honda, Yoshihiro, Sugawara, Shunichi
Published in Sarcoidosis, vasculitis, and diffuse lung diseases (01.01.2019)
Published in Sarcoidosis, vasculitis, and diffuse lung diseases (01.01.2019)
Get full text
Journal Article
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer
Aso, Mari, Toi, Yukihiro, Sugisaka, Jun, Aiba, Tomoiki, Kawana, Sachiko, Saito, Ryohei, Ogasawara, Takahiro, Tsurumi, Kyoji, Ono, Kana, Shimizu, Hisashi, Domeki, Yutaka, Terayama, Keisuke, Kawashima, Yosuke, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro, Sugawara, Shunichi
Published in The oncologist (Dayton, Ohio) (07.11.2019)
Get full text
Published in The oncologist (Dayton, Ohio) (07.11.2019)
Journal Article